Drug Type Small molecule drug |
Synonyms Esimil |
Target |
Action inhibitors, modulators |
Mechanism NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors), SLC6A2 modulators(Norepinephrine transporter modulators) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseWithdrawn |
First Approval Date United States (01 Jan 1982) |
Regulation- |
Molecular FormulaC7H8ClN3O4S2 |
InChIKeyJZUFKLXOESDKRF-UHFFFAOYSA-N |
CAS Registry58-93-5 |